<DOC>
	<DOC>NCT02149290</DOC>
	<brief_summary>This study will evaluate the accuracy of data on body position, daily activity, heart rate, 6-minute walk test, and a health survey collected by the wearable cardioverter defibrillator (WCD).</brief_summary>
	<brief_title>LifeVest Trends Validation Protocol</brief_title>
	<detailed_description>This is a multi-center validation study of heart failure patients wearing the LifeVest WCD modified to collect data on body position, activity, heart rate, 6-minute walk test, and a health survey in order to evaluate data accuracy and patient interactions with the device.</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Symptomatic heart failure (i.e., New York Heart Association (NYHA) class II or higher) Evidence of a prior Myocardial Infarction (MI) or dilated cardiomyopathy Ejection fraction of 35% or less at the start of WCD use Anticipated to need a WCD for three months or more At least 18 years of age (over the legal age of providing consent) Use of an implantable cardioverter defibrillator (ICD), recent removal of an ICD, or planned use of an ICD within the next three months Need for an assistive device for ambulation (wheelchair, walker, or cane) Use of a unipolar pacemaker Physical or mental conditions that prevent interaction with or wearing of the device Advanced directive prohibiting resuscitation Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Heart Failure</keyword>
	<keyword>Six minute walk test</keyword>
</DOC>